Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.

Prostaglandin G/H synthase (PGHS), a key enzyme leading to the formation of prostaglandins, is the target of nonsteroidal antiinflammatory drugs. Two forms of the enzyme have been identified, PGHS-1 and PGHS-2. Epidemiological evidence has suggested that aspirin and other nonsteroidal antiinflammatory drugs may reduce the risk of colorectal cancer. We examined by immunoblot analyses the expression of human PGHS-1 and PGHS-2 protein in 25 matched colon cancer and nontumor tissues, 4 premalignant polyps, 5 control colon tissues from noncancer patients, and 3 matched normal and cancerous breast tissue samples. PGHS-1 was detected in all normal and tumor tissue. In contrast, PGHS-2 was not detected in 23 of 25 normal colon tissues but was detected in 19 of 25 colon tumors. PGHS-2 protein was not observed in four human premalignant polyp samples, control colon from noncancer patients, or matched normal or cancerous breast tissues. These results suggest that the beneficial effects of nonsteroidal antiinflammatory drugs in colon cancer may be mediated by inhibition of PGHS-2.

[1]  T. Żebro,et al.  Prostaglandins from tumours of human large bowel. , 1977, British Journal of Cancer.

[2]  K. Seibert,et al.  Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Dewitt,et al.  PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs. , 1993, The American journal of medicine.

[4]  J. Falgueyret,et al.  Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid. , 1994, Molecular pharmacology.

[5]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Lavori,et al.  Effect of sulindac on sporadic colonic polyps. , 1995, Gastroenterology.

[7]  S. Hart,et al.  Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. , 1992, The Journal of biological chemistry.

[8]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[9]  D. Dewitt.  Prostaglandin endoperoxide synthase: regulation of enzyme expression. , 1991, Biochimica et biophysica acta.

[10]  M. Boyd,et al.  Profiles of prostaglandin biosynthesis in normal lung and tumor tissue from lung cancer patients. , 1988, Cancer research.

[11]  K. Resch,et al.  Differentiation‐associated expression of prostaglandin G/H synthase in monocytic cells , 1993, FEBS letters.

[12]  R. Coffey,et al.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.

[13]  S. Higuchi,et al.  NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. , 1993, General pharmacology.

[14]  W. Xie,et al.  Mitogen‐inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs , 1992 .

[15]  J. Otto,et al.  N-glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum. , 1993, The Journal of biological chemistry.

[16]  P. Falardeau.  [Prostaglandins in clinical practice]. , 1988, L'union medicale du Canada.

[17]  B. Rigas,et al.  Altered eicosanoid levels in human colon cancer. , 1993, The Journal of laboratory and clinical medicine.

[18]  S. Higuchi,et al.  NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. , 1994, Prostaglandins.

[19]  D. Alberts,et al.  Piroxicam and other cyclooxygenase inhibitors: Potential for cancer chemoprevention , 1992, Journal of cellular biochemistry. Supplement.

[20]  M. Thun,et al.  Nonsteroidal antiinflammatory drugs and human cancer. Report of an interdisciplinary research workshop , 1994, Cancer.